Specialties
Reports that name this provider
- Hyperthermia Treatment in Germany
- Private oncology facility. Markets to patients from US, UK, Australia, and Middle East. Core 7-day programs start from €11,000. Immunotherapy add-ons from €18,000. Criticized for combining guideline-approved treatments with unproven complementary approaches.
- Integrative Oncology Quality in Germany
- Actively markets to US, UK, Australian, and Middle Eastern patients for integrative oncology alongside conventional cancer care. Offers homeopathy, ozone therapy, and orthomolecular treatments. Report notes the clinic has attracted criticism for offering scientifically unsupported therapies without publishing patient outcome data.